Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.49 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | MMP14 | P50281 | 1/20 | 0.46 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | FBP1 | P09467 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL26923048 | 0.98 | FFAR4 (0.47) | FFAR4BCHEACHEMMP2MMP9 | |
| SCHEMBL3310741 | 0.94 | MMP9 (0.54) | FFAR4BCHEACHEMMP2MMP9 | |
| SCHEMBL21556097 | 0.84 | ALDH1A1 (0.40) | FFAR4BCHEACHEMMP2MMP9 | |
| SCHEMBL6632895 | 0.82 | ALDH1A1 (0.39) | FFAR4BCHEACHEMMP2MMP9 | |
| SCHEMBL1489401 | 0.82 | TRPV1 (0.40) | FFAR4BCHEACHEMMP2MMP9 | |
| SCHEMBL11683700 | 0.81 | ALDH1A1 (0.38) | FFAR4BCHEACHEMMP2MMP9 | |
| SCHEMBL13542559 | 0.81 | FFAR4 (0.50) | FFAR4BCHEACHEMMP2MMP9 | |
| SCHEMBL27245279 | 0.81 | TRPV1 (0.68) | EPHX2 | |
| SCHEMBL24903837 | 0.80 | FFAR4 (0.47) | FFAR4BCHEACHEMMP2MMP9 | |
| SCHEMBL4190483 | 0.79 | FFAR4 (0.38) | FFAR4BCHEACHEMMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1521 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12522575-B2 | 2-diarylmethyl-4-aminotetrahydropyran derivatives and related compounds as anticancer, antiinflammatory, antifibrotic and neuroprotective agents | ATUX ISKAY LLC (US) | 2026-01-13 | — | — | US | claimed |
| US-20250376455-A1 | 2-DIARYLMETHYL-4-AMINOTETRAHYDROPYRAN DERIVATIVES AND RELATED COMPOUNDS AS ANTICANCER, ANTIINFLAMMATORY, ANTIFIBROTIC AND NEUROPROTECTIVE AGENTS | ATUX ISKAY LLC (US) | 2025-12-11 | — | — | US | claimed |
| CN-120082181-A | PBAT/bamboo powder biodegradable composite master batch, preparation method thereof and composite film | 国际竹藤中心 | 2025-06-03 | — | — | CN | claimed |
| CN-119425423-A | Positively charged composite membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-113173891-A | Molecular probe derived from calcium-sensitive receptor protein antagonist and application of molecular probe in parathyroidectomy | 大连医科大学附属第二医院 | 2021-07-27 | — | — | CN | claimed |
| CN-109608369-B | Sulfonyl ester group anthraquinone derivative and preparation method and application thereof | 广西大学 | 2021-04-09 | — | — | CN | claimed |
| CN-110452146-A | Trifluoromethyl seleno-amino acids derivative and preparation method thereof | UNIV WUHAN TECH | 2019-11-15 | — | — | CN | claimed |
| CN-109608369-A | Sulphonyl ester group anthraquinone derivatives and its preparation method and application | 广西大学 | 2019-04-12 | — | — | CN | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| US-6713220-B2 | RESISTANCE TO LIGHT SHOCK; CHARGE TRANSPORT LAYER CONTAINS DIPHENOQUINONE 3,3',5,5'-TETRA-TERT-BUTYL-4,4'-DIPHENOQUINONE TO ABSORB LIGHT OF WAVELENGTH LESS THAN 700 NM; PHOTOGENERATOR IS A HYDROXYGALLIUM PHTHALOCYANINE | XEROX CORPORATION | 2004-03-30 | — | — | US | claimed |
| CN-122080012-A | Thienopyrimidine derivative, preparation method, application and pharmaceutical composition thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122079918-A | Isoxazole biphenyl compounds with CBP BRD and BRD4 BD2 inhibitory activity, and preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4741018-A2 | SULPHONAMIDE COMPOUNDS | Anaxis Pharma Pty Ltd (AU) | 2026-05-13 | — | — | EP | disclosed |
| US-12611404-B2 | Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides | CHEMOCENTRYX, INC. (US) | 2026-04-28 | — | — | US | disclosed |
| US-12606522-B2 | Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives | ORSOBIO, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| WO-1996033160-A1 | DIHALOPROPENE COMPOUNDS, INSECTICIDES CONTAINING THEM AS ACTIVE INGREDIENTS, AND INTERMEDIATES FOR THEIR PRODUCTION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-10-24 | — | — | WO | disclosed |
| WO-1996025934-A1 | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1996-08-29 | — | — | WO | disclosed |
| EP-0659181-A1 | SULFONAMIDE INHIBITORS OF HIV-ASPARTYL PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1995-06-28 | — | — | EP | disclosed |
| CN-1087347-A | The new sulfonamide inhibitors of aspartyl protease | VERTEX PHARMA (US) | 1994-06-01 | — | — | CN | disclosed |
| WO-1994005639-A1 | SULFONAMIDE INHIBITORS OF HIV-ASPARTYL PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1994-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12611404-B2 | Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides | CCR1, CCR9, CCR8 | FFAR4 227/4885BCHE 2992/4885ACHE 4877/4885 |
| US-12606522-B2 | Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives | NR3C2, NR5A1, SRD5A2 | FFAR4 212/4885BCHE 1834/4885ACHE 4044/4885 |
| US-20250376455-A1 | 2-DIARYLMETHYL-4-AMINOTETRAHYDROPYRAN DERIVATIVES AND RELATED COMPOUNDS AS ANTICANCER, ANTIINFLAMMATORY, ANTIFIBROTIC AND NEUROPROTECTIVE AGENTS | MYC, MYCBP, MYCBP2 | FFAR4 3864/4885BCHE 4364/4885ACHE 3393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.